IonQ Stock Up 16% Since Q2 Earnings: Should You Buy or Book Profits?
📈 IonQ shares surged 15.9% since the August 5, 2026 Q2 earnings release, outperforming competitors Rigetti Computing (+12.1%) and D-Wave Quantum (-1%).
💰 Revenue jumped 287% year over year, with remaining performance obligations reaching $485 million.
🚀 The company raised its 2026 revenue outlook to $280-$290 million, excluding the recently completed SkyWater acquisition.
🏭 IonQ completed the SkyWater acquisition, creating a vertically integrated U.S. quantum manufacturing platform.
🤝 New defense and national-security initiatives with Anduril and Sandia National Laboratories expand government market opportunities.
💼 60% of revenues now come from commercial customers, while international and multi-product segments represent 50% and 25% respectively.
📊 RPO (Remaining Performance Obligations) climbed 297% year over year, supporting the raised revenue guidance.
📉 The stock trades at a premium 46.51x P/S versus the S&P 500's 5.03x, carrying a Zacks Rank #4 (Sell).
📈 Technically, IONQ is trading above its 50-day and 200-day moving averages after a July selloff.
🔮 Management expects $135-$145 million in second-half revenues with no anticipated sequential decline.
- IonQ reported a massive 287% year-over-year revenue increase, significantly outperforming its prior guidance by 20%.
- The company raised its full-year 2026 revenue outlook to $280-$290 million, projecting over 100% organic growth for the remainder of the year.
- Completion of the SkyWater acquisition strengthens IonQ's vertically integrated U.S. manufacturing strategy and quantum roadmap.
- Commercial momentum is accelerating with 60% of revenues now derived from commercial customers, reducing reliance on government contracts.
- New strategic partnerships with Anduril and Sandia National Laboratories are expanding the company's addressable defense and national-security market.
- Remaining performance obligations reached $485 million, while RPO climbed 297% year over year, indicating strong future revenue visibility.
- The stock trades at a demanding valuation of 46.51x sales, representing a roughly 9.2x premium to the S&P 500.
- Analysts note that limited technical cushion above moving averages suggests much of the near-term optimism may already be priced in.